Effects of benzo[a]pyrene, aromatic amines, and a combination of both on CYP1A1 activities in RT-4 human bladder papilloma cells

References

• Autrup, H., Grafstrom, R. C., Christensen, B., and Kieler, J. 1981. Metabolism of chemical carcinogens by cultured human and rat bladder epithelial cells. Carcinogenesis 2: 763–68.
   PubMed Web of Science ®Google Scholar
• Bièche, I., Narjoz, C., Asselah, T., Vacher, S., Marcellin, P., Lidereau, R., Beaune, P., and de Waziers, I. 2007. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet. Genomics 17: 731–42.
   PubMed Web of Science ®Google Scholar
• Boffetta, P., Jourenkova, N., and Gustavsson, P. 1997. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 8: 444–72.
   PubMed Web of Science ®Google Scholar
• Bolt, H. M. 2014. Causation of human urothelial cancer: There are challenging new data! Arch. Toxicol. 88: 1769–70.
   Web of Science ®Google Scholar
• Borenfreund, E., and Puerner, J. A. 1985. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol. Lett. 24: 119–24.
   PubMed Web of Science ®Google Scholar
• Borza, A., Plöttner, S., Wolf, A., Behm, C., Selinski, S., Hengstler, J. G., Roos, P. H., Bolt, H. M., Kuhlmann, J., and Föllmann, W. 2008. Synergism of aromatic amines and benzo[a]pyrene in induction of Ah receptor-dependent genes. Arch. Toxicol. 82: 973–80.
   PubMed Web of Science ®Google Scholar
• Bosetti, C., Boffetta, P., and La Vecchia, C. 2007. Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: a quantitative review to 2005. Ann. Oncol. 18: 431–46.
   PubMed Web of Science ®Google Scholar
• Brauers, A., Manegold, E., Buettner, R., Baron, J. M., Merk, H. F., and Jakse, G. 2000. Cytochrome P450 isoenzyme mRNA expression pattern in human urinary bladder malignancies and normal urothelium. Cancer Detect. Prev. 24: 356–63.
   PubMedGoogle Scholar
• Cali, J. J., Ma, D., Sobol, M., Simpson, D. J., Frackman, S., Good, T. D., Daily, W. J., and Liu, D. 2006. Luminogenic cytochrome P450 assays. Expert Opin. Drug Metab. Toxicol. 2: 629–45.
   PubMed Web of Science ®Google Scholar
• DFG. 2014. List of MAK and BAT values 2014. In List of MAK and BAT values 2014: Maximum concentrations and biological tolerance values at the workplace. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 161–172.
   Google Scholar
• Dörrenhaus, A., Müller, T., and Roos, P. H. 2007. Increased CYP1A1 expression in human exfoliated urothelial cells of cigarette smokers compared to non-smokers. Arch. Toxicol. 81: 19–25.
   PubMed Web of Science ®Google Scholar
• Eble, J. N., Sauter, G., Epstein, J. I., and Sesterhenn, I. A. 2004. Pathology and genetics of tumours of the urinary system and male genital organs. World Health Organization Classification of Tumours. Lyon, France: IARC Press.
   Google Scholar
• Föllmann, W., Blaszkewicz, M., Behm, C., Degen, G. H., and Golka, K. 2012. N-Acetylation of p-aminobenzoic acid and p-phenylenediamine in primary porcine urinary bladder epithelial cells and in the human urothelial cell line 5637. J. Toxicol. Environ. Health A 75: 1206–15.
   PubMed Web of Science ®Google Scholar
• Guhe, C., Degen, G. H., Schuhmacher, U. S., Kiefer, F., and Föllmann, W. 1996. Drug metabolizing enzyme activities in porcine urinary bladder epithelial cell cultures (PUBEC). Arch. Toxicol. 70: 599–606.
   PubMed Web of Science ®Google Scholar
• Gundert-Remy, U., Bernauer, U., Blömeke, B., Döring, B., Fabian, E., Goebel, C., Hessel, S., Jäckh, C., Lampen, A., Oesch, F., Petzinger, E., Völkel, W., and Roos, P. H. 2014. Extrahepatic metabolism at the body’s internal-external interfaces. Drug Metab. Rev. 46: 291–324.
   PubMed Web of Science ®Google Scholar
• IARC. 1987. Overall evaluations of carcinogenicity: An updating of IARC Monographs Volumes 1 to 42. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 7. Lyon, France: WHO Press.
   Google Scholar
• IARC. 2004. Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 83. Lyon, France: WHO Press.
   Google Scholar
• IARC. 2012. Chemical agents and related occupations. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 100 F. Lyon, France: WHO Press.
   Google Scholar
• Imaoka, S., Yoneda, Y., Sugimoto, T., Hiroi, T., Yamamoto, K., Nakatani, T., and Funae, Y. 2000. CYP4B1 is a possible risk factor for bladder cancer in humans. Biochem. Biophys. Res. Commun. 277: 776–80.
   PubMed Web of Science ®Google Scholar
• Ioannides, C., Lewis, D. F., Trinick, J., Neville, S., Sertkaya, N. N., Kajbaf, M., and Gorrod, J. W. 1989. A rationale for the non-mutagenicity of 2- and 3-aminobiphenyls. Carcinogenesis 10: 1403–7.
   PubMed Web of Science ®Google Scholar
• Iwanari, M., Nakajima, M., Kizu, R., Hayakawa, K., and Yokoi, T. 2002. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: Chemical-, cytochrome P450 isoform-, and cell-specific differences. Arch. Toxicol. 76: 287–98.
   PubMed Web of Science ®Google Scholar
• Juricek, L., Bui, L. C., Busi, F., Pierre, S., Guyot, E., Lamouri, A., Dupret, J. M., Barouki, R., Coumoul, X., and Rodrigues-Lima, F. 2015. Activation of the aryl hydrocarbon receptor by carcinogenic aromatic amines and modulatory effects of their N-acetylated metabolites. Arch. Toxicol. 89: 2403–12.
   PubMed Web of Science ®Google Scholar
• Kim, D., and Guengerich, F. P. 2005. Cytochrome P450 activation of arylamines and heterocyclic amines. Annu. Rev. Pharmacol. Toxicol. 45: 27–49.
   PubMed Web of Science ®Google Scholar
• Ma, Q., and Lu, A. Y. H. 2007. CYP1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies. Drug Metab. Dispos. 35: 1009–16.
   PubMed Web of Science ®Google Scholar
• Murray, G. I., Melvin, W. T., Greenlee, W. F., and Burke, M. D. 2001. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu. Rev. Pharmacol. Toxicol. 41: 297–316.
   PubMed Web of Science ®Google Scholar
• Neumann, H. G. 2010. Aromatic amines: mechanisms of carcinogenesis and implications for risk assessment. Front. Biosci. 15: 1119–30.
   Web of Science ®Google Scholar
• Plöttner, S., Borza, A., Wolf, A., Bolt, H. M., Kuhlmann, J., and Föllmann, W. 2008a. Evaluation of time-dependence and interindividual differences in benzo[a]pyrene-mediated CYP1A1 induction and genotoxicity in porcine urinary bladder cell cultures. J. Toxicol. Environ. Health A 71: 969–75.
   PubMed Web of Science ®Google Scholar
• Plöttner, S., Degen, G. H., Roos, P. H., and Föllmann, W. 2008b. Analysis of CYP1A1 induction in single cells of urothelial cell populations by flow cytometry. Anal. Bioanal. Chem. 392: 1149–58.
   PubMed Web of Science ®Google Scholar
• Roos, P. H., Belik, R., Föllmann, W., Degen, G. H., Knopf, H. J., Bolt, H. M., and Golka, K. 2006. Expression of cytochrome P450 enzymes CYP1A1, CYP1B1, CYP2E1 and CYP4B1 in cultured transitional cells from specimens of the human urinary tract and from urinary sediments. Arch. Toxicol. 80: 45–52.
   PubMed Web of Science ®Google Scholar
• Roos, P. H., and Bolt, H. M. 2005. Cytochrome P450 interactions in human cancers: New aspects considering CYP1B1. Expert Opin. Drug Metab. Toxicol. 1: 187–202.
   PubMedGoogle Scholar
• Rota, M., Bosetti, C., Boccia, S., Boffetta, P., and La Vecchia, C. 2014. Occupational exposures to polycyclic aromatic hydrocarbons and respiratory and urinary tract cancers: An updated systematic review and a meta-analysis to 2014. Arch. Toxicol. 88: 1479–90.
   PubMed Web of Science ®Google Scholar
• Scélo, G., and Brennan, P. 2007. The epidemiology of bladder and kidney cancer. Nat. Clin. Pract. Urol. 4: 205–17.
   PubMedGoogle Scholar
• Stoner, G. D., Daniel, F. B., Schenck, K. M., Schut, H. A., Goldblatt, P. J., and Sandwisch, D. W. 1982. Metabolism and DNA binding of benzo[a]pyrene in cultured human bladder and bronchus. Carcinogenesis 3: 195–201.
   PubMed Web of Science ®Google Scholar
• Straif, K., Baan, R., Grosse, Y., Secretan, B., El Ghissassi, F., and Cogliano, V. 2005. Carcinogenicity of polycyclic aromatic hydrocarbons. Lancet Oncol. 6: 931–32.
   PubMed Web of Science ®Google Scholar
• Talaska, G. 2003. Aromatic amines and human urinary bladder cancer: Exposure sources and epidemiology. J. Environ. Sci. Health C Environ. Carcinogen. Ecotoxicol. Rev. 21: 29–43.
   PubMed Web of Science ®Google Scholar
• Vaziri, S. A., Hughes, N. C., Sampson, H., Darlington, G., Jewett, M. A., and Grant, D. M. 2001. Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects. Pharmacogenetics 11: 7–20.
   PubMedGoogle Scholar
• Wolf, A., Kutz, A., Plöttner, S., Behm, C., Bolt, H. M., Föllmann, W., and Kuhlmann, J. 2005. The effect of benzo(a)pyrene on porcine urinary bladder epithelial cells analyzed for the expression of selected genes and cellular toxicological endpoints. Toxicology 207: 255–69.
   PubMed Web of Science ®Google Scholar
• Xue, W., and Warshawsky, D. 2005. Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: A review. Toxicol. Appl. Pharmacol. 206: 73–93.
   PubMed Web of Science ®Google Scholar